Search Within

Odette Marsinay Smith

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Meeting Abstract (16)
  2. Journal Article (5)
Groups
  1. Center for Hematologic Malignancies (21)
  2. Department of Medicine (21)
  3. Executive Committee, Center for Hematologic Malignancies (21)
  4. GSK Faculty (21)
  5. Hematologic Malignancies, Division of (21)
  6. Immunology Program Faculty (21)

More Groups

People
  1. Marcel Van Den Brink (21)
  2. Robert Jenq (20)
  3. Amanda Holland (17)
  4. Alan Hanash (15)
  5. Arnab Ghosh (12)
  6. Lauren Young (12)

More People

Years
  1. 2015 (2)
  2. 2014 (1)
  3. 2013 (2)
  4. 2012 (4)
  5. 2011 (4)
  6. 2010 (3)

More Years

Publications
  1. Blood (8)
  2. Biology of Blood and Marrow Transplantation (6)
  3. Bone Marrow Transplantation (1)
  4. Cancer Research (1)
  5. Immunity (1)
  6. JNCI: Journal of the National Cancer Institute (1)

More Publications

Publishers
  1. American Society of Hematology (8)
  2. Elsevier Inc. (6)
  3. Nature Publishing Group (3)
  4. American Association for Cancer Research (1)
  5. American Society for Clinical Investigation (1)
  6. Cell Press (1)

More Publishers

Results (21)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration
    Journal Article

    Lindemans, C. A.; Calafiore, M.; Mertelsmann, A. M.; O'Connor, M. H.; Dudakov, J. A.; Jenq, R. R.; Velardi, E.; Young, L. F.; Smith, O. M.; Lawrence, G.; more...
    Nature (2015)

    Fulltext@MSK | Save
  • IL-22 directly regulates intestinal stem cells, protecting epithelium from GVHD and reducing GVHD mortality
    Meeting Abstract

    Lindemans, C. A.; Mertelsmann, A.; O'connor, M.; Calafiore, M.; Dudakov, J. A.; Jenq, R.; Velardi, E.; Young, L.; Smith, O. M.; Lawrence, G.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • IL-22 is an intestinal stem cell growth factor, and IL-22 administration in vivo reduces morbidity and mortality in murine GvHD
    Meeting Abstract

    Lindemans, C. A.; Mertelsmann, A.; O'Connor, M. H.; Dudakov, J. A.; Jenq, R.; Velardi, E.; Young, L. F.; Smith, O. M.; Lawrence, G.; Luo, N.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • IL-22 administration decreases intestinal GVHD pathology, increases intestinal stem cell recovery, and enhances immune reconstitution following allogeneic hematopoietic transplantation
    Meeting Abstract

    Mertelsmann, A. M.; Dudakov, J. A.; Velardi, E.; Hua, G.; Kreines, F. M.; Levy, E. R.; O'Connor, M.; Smith, O. M.; Kolesnick, R.; van den Brink, M. R. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity
    Journal Article

    Ghosh, A.; Dogan, Y.; Moroz, M.; Holland, A. M.; Yim, N. L.; Rao, U. K.; Young, L. F.; Tannenbaum, D.; Masih, D.; Velardi, E.; more...
    Journal of Clinical Investigation (2013)

    Fulltext@MSK | Save
  • CD19-targeted donor T cells exert potent graft versus lymphoma activity and attenuated GVHD
    Meeting Abstract

    Ghosh, A.; Davila, M. L.; Young, L. F.; Kloss, C.; Gunset, G.; Smith, O. M.; West, M. L.; Singer, N. V.; Holland, A. M.; Jenq, R. R.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease
    Journal Article

    Hanash, A.; Dudakov, J.; Hua, G.; O'connor, M.; Young, L.; Singer, N.; West, M.; Jenq, R.; Holland, A.; Kappel, L.; more...
    Immunity (2012)

    Fulltext@MSK | Save
  • Host-derived IL-22 protects intestinal stem cells from GVHD
    Meeting Abstract

    Hanash, A.; Dudakov, J.; Hua, G.; O'connor, M.; Jenq, R.; Holland, A.; Smith, O.; Liu, C.; Fouser, L.; Kolesnick, R.; more...
    Biology of Blood and Marrow Transplantation (2012)

    Fulltext@MSK | Save
  • Trail over-expression on donor T cells enhances GVT and suppresses GVHD by inhibiting alloreactive T cells and impairing host APC functions
    Meeting Abstract

    Ghosh, A.; Dogan, Y.; Holland, A. M.; Young, L. F.; West, M. L.; Singer, N. V.; Smith, O. M.; Jenq, R. R.; Na, I. K.; Penack, O.; more...
    Biology of Blood and Marrow Transplantation (2012)

    Fulltext@MSK | Save
  • Genetically engineered allogeneic T Cells for BMT immunotherapy: Expression of TRAIL and PLZF selectively enhances GVT and abrogates GVHD
    Meeting Abstract

    Ghosh, A.; Holland, A. M.; Dogan, Y.; Yim, N.; Rao, U. K.; Young, L. F.; Smith, O. M.; Jenq, R.; Na, I. K.; Tsai, J. J.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save